October 7, 2022

A University of Cincinnati Venture Lab-backed startup is developing a breast cancer treatment that may be more effective with fewer side effects thanks to RNA nanotechnology that is similar to what was used to produce COVID-19 vaccines.

September 19, 2023

Ask someone what life-changing scientific breakthrough they might want to be remembered for, and it’s a fair bet they’ll say “Curing cancer.” RNA Nanotherapeutics is bringing that answer a step closer, thanks to the research of Xiaoting Zhang, the John and Gladys Strauss Endowed Chair in Cancer Research and director of the Breast Cancer Research Program of the University of Cincinnati’s Department of Cancer Biology. UC’s Venture Lab helped him launch a discovery that could transform the treatment of breast cancer.

May 5, 2023

A hands-free device developed by researchers at the University of Cincinnati could help the 12.5 million Americans who have chronic obstructive pulmonary disease breathe easier, Action News 5 in Memphis, Tennessee, reported.